UCT4B, a new antitumor antibiotic with topoisomerase II mediated DNA cleavage activity.

  • UOSAKI YOUICHI
    Tokyo Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.
  • KAWADA SHO-ZOU
    Tokyo Research Laboratories, Kyowa Hakko Kogyo Co., Ltd. Technical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.
  • NAKANO HIROFUMI
    Tokyo Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.
  • SAITOH YUTAKA
    Tokyo Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.
  • SANO HIROSHI
    Tokyo Research Laboratories, Kyowa Hakko Kogyo Co., Ltd. Shimizu Institute, Marine Biotechnology Institute Co., Ltd.

書誌事項

タイトル別名
  • STRUCTURE DETERMINATION

この論文をさがす

説明

The relative stereo structure of UCT4B was determined by means of chemical derivatization and spectral analysis, in relation to known antitumor antibiotics terpentecin, which was simultaneously produced with UCT4B by Streptomyces sp.

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

  • CRID
    1390282679127687936
  • NII論文ID
    130003502464
  • DOI
    10.7164/antibiotics.46.235
  • COI
    1:CAS:528:DyaK3sXktVymtL8%3D
  • ISSN
    18811469
    00218820
  • PubMed
    8385658
  • 本文言語コード
    en
  • 資料種別
    journal article
  • データソース種別
    • JaLC
    • Crossref
    • PubMed
    • CiNii Articles
  • 抄録ライセンスフラグ
    使用不可

問題の指摘

ページトップへ